|
How many volunteers were present at the Congress? : |
300 |
|
Delegates from which countries presented in the congress? : |
Uk, all European countries, Canada, ... |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
ASPET |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
There were specific comments by the editor of Journal of clinical Pharmacology regarding my work. The specific question that was raised regarding this poster presentation was the fact that how this antihyperlipidemic drug clofibrate has antiarrhythmic effect and I discussed the important pathways that this drug might affect and more work needed to clarify this point. |
|
If you met staff members, please list their full names & positions. : |
No |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
Since My work was not presented orally therefore any comments needed when the people came to my poster presentation , I tried to answer their questions. They commented that my work can be done in vivo and after looking at the molecular level we could have better results and could publish it with European journals . “Based on the findings, clofibrate may possess potentials to reduce some kinds of cardiac arrhythmias. Further studies especially on in vivo arrhythmial models can more elucidate these beneficial effects of this drug.” |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Because of Iran Air delay, we missed our flight to Geneva. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
It was a great pleasure for me to attend the the 11th Conference of the European Association for Clinical Pharmacology and Therapeutics (EACPT) in Geneva. This congress was under the auspices of the Swiss Society of Clinical Pharmacology and Toxicology and the other sponsors, the Congress took place from 28 to 31 August 2013 at the International Conference Center Geneva (CICG), in the smallest of the world class metropolis. Clinical pharmacology provides a wide array of services, from excellence in patient care, teaching and clinical research to high standard efficient contribution in drug development and professional services in regulatory bodies. The Conference was a unique opportunity to meet top ranking specialists of various professional backgrounds involved in drug discovery, drug development, pharmacology and pharmacotherapy teaching, drug use, drug epidemiology, and drug safety.
This meeting was a good clinical Pharmacolgy congress and it was well organized. |